BACKGROUND AND OBJECTIVES
Mechanical thrombectomy (MT) is the standard of care for acute ischemic stroke from large vessel occlusion (LVO). Although postprocedural parenchymal hematoma (PH) predicts poor outcomes, pretreatment hemorrhagic infarction (HI), defined as petechial bleeding within infarcted tissue, is tradit...
T. Goulart, M. Schirmer, A. Bonkhoff et al.· Neurology· 0 citations
Background: Mechanical thrombectomy (MT) is the standard of care for large vessel occlusion (LVO) stroke, yet nearly half of patients fail to achieve functional independence. Cerebral small vessel disease (CSVD) represents a marker of brain frailty that may impair recovery. Objective: We aimed to evaluate whether compr...
Thiago Oscar Goulart, Markus Schirmer, Yuan Ma et al.· ANPAbstract_CBN26· 0 citations
HI detected on pre-treatment MRI is associated with worse functional outcomes and increased risk of hemorrhagic complications after thrombectomy, and may serve as a prognostic marker of reperfusion vulnerability and warrants further study as a target for neuroprotective strategies.
Thiago Oscar Goulart, M. Schirmer, Yuan Ma et al.· ANPAbstract_CBN26· 0 citations
It is suggested that while CSVD assessment improves post-thrombectomy prognostication, it should not be used as a criterion to preclude patients from MT eligibility and cumulative total CSVD burden acts as a strong, dose-dependent predictor of functional outcomes and symptomatic hemorrhage.
Thiago Oscar Goulart, Markus Schirmer, Yuan Ma et al.· International Journal of Str...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.